Clinical Trial Update: Memantine Hydrochloride for Treatment of Cognitive Dysfunction Due to Traumatic Brain Injury [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating memantine hydrochloride for cognitive deficits after traumatic brain injury has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Traumatic Brain Injury

Drugs mentioned

• Memantine (memantine)

Snippet

Sponsor: Assiut University | Conditions: Treatment of Cognitive Deficits After Traumatic Brain Injury | Phase 3 | Status: COMPLETED